Aprogen Medicines Inc. (KRX:007460)
South Korea · Delayed Price · Currency is KRW 2,140.00
+164.00 (8.30%)
At close: Oct 2, 2026
Aprogen Medicines Market Cap
Aprogen Medicines has a market cap or net worth of 47.53 billion as of October 2, 2026. Its market cap has decreased by -75.76% in one year.
Market Cap
47.53B
Enterprise Value
539.52B
Revenue
138.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,140.00
ChartMarket Cap Chart
Since December 7, 1995, Aprogen Medicines's market cap has increased from 19.56B to 47.53B, an increase of 143.03%. That is a compound annual growth rate of 2.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 47.53B | -77.90% |
| Dec 30, 2025 | 215.06B | -2.20% |
| Dec 30, 2024 | 219.89B | -6.16% |
| Dec 28, 2023 | 234.32B | -41.38% |
| Dec 27, 2022 | 399.71B | 19.11% |
| Dec 30, 2021 | 335.57B | -10.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon | 326.45B |
| KG Chemical | 285.07B |
| HS HYOSUNG | 185.46B |
| Woongjin | 143.23B |
| JLK, Inc. | 131.24B |
| Gridwiz | 103.10B |
| HLB GLOBAL | 94.43B |
| AK Holdings | 91.19B |